Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: report of a case and review of the literature by Franceschini, G et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Cancer
Open Access Case report
Gastro-intestinal symptoms as clinical manifestation of peritoneal 
and retroperitoneal spread of an invasive lobular breast cancer: 
report of a case and review of the literature
G Franceschini*1, A Manno1, A Mulè2, A Verbo1, G Rizzo1, D Sermoneta1, 
L Petito1, P D'alba1, C Maggiore2, D Terribile1, R Masetti1 and C Coco1
Address: 1Dept of Surgery, Università Cattolica del Sacro Cuore, Rome, Italy and 2Dept of Pathology, Università Cattolica del Sacro Cuore, Rome, 
Italy
Email: G Franceschini* - g.franceschini@rm.unicatt.it; A Manno - alberto.manno@rm.unicatt.it; A Mulè-a n t o n i o . m u l e @ r m.unicatt.it; 
A Verbo - a.verbo@rm.unicatt.it; G Rizzo - gianluca.rizzo1979@libero.it; D Sermoneta - daniel.s@tiscali.it; L Petito - otitep@libero.it; 
P D'alba - pierfrancesco.dalba@rm.unicatt.it; C Maggiore - claudiamaggiore@yahoo.it; D Terribile - dterribile@rm.unicatt.it; 
R Masetti - r.masetti@rm.unicatt.it; C Coco - coco_claudio@rm.unicatt.it
* Corresponding author    
Abstract
Background: Distant spread from breast cancer is commonly found in bones, lungs, liver and
central nervous system. Metastatic involvement of peritoneum and retroperitoneum is unusual and
unexpected.
Case presentation: We report the case of a 67 year-old-woman who presented with
gastrointestinal symptoms which revealed to be the clinical manifestations of peritoneal and
retroperitoneal metastatic spread of an invasive lobular breast cancer diagnosed 15 years before.
Conclusion: To the best of our knowledge, the case presented is the third one reported in
literature showing a wide peritoneal and extraperitoneal diffusion of an invasive lobular breast
cancer. The long and complex diagnostic work up which led us to the diagnosis is illustrated, with
particular emphasis on the multidisciplinary approach, which is mandatory to obtain such a result
in these cases. Awareness of such a condition by clinicians is mandatory in order to make an early
diagnosis and start a prompt and correct therapeutic approach.
Background
Invasive lobular breast cancer (ILC) takes origin in the
milk-producing glands of the breast and is the most com-
mon histological breast cancer after the ductal carcinoma
(DC), accounting for 8–14% of cases [1]. The typical his-
tologic picture is characterized by small, regular, non-
cohesive cells arranged in the so called "Indian file"
appearance [2]; the neoplastic cells infiltrate the paren-
chyma around non-neoplastic ducts, inducing little con-
nective tissue response [3]. Being physical examination
and mammography often non-specific, contrast-
enhanced magnetic resonance imaging (MRI) represents
the gold standard for a correct diagnosis [4]. ILC has a
higher tendency than DC to be multi-focal and bilateral
[5]. Also the pattern of metastatic spread differs signifi-
cantly between these 2 kinds of breast tumours, with a
more common occurrence of unusual location of distant
neoplastic foci, especially in the gastrointestinal tract, the
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genitourinary system and the peritoneum or retroperito-
neum, secondary to ILC. This event is unexpected, usually
with a long interval after the initial diagnosis of ILC, and
the presenting symptoms as well as the endoscopic and
the radiographic pictures are often non-specific. These
conditions lead to a frequent delay in diagnosis which
prevents the prompt starting of systemic treatment neces-
sary to obtain a good control of symptoms. The case
reported gives an example of this unusual metastatic dif-
fusion and of the complex diagnostic work up which led
us to he diagnosis.
Case presentation
A 67-year-old woman underwent right modified radical
mastectomy and axillary lymph node dissection for carci-
noma of the breast 15 years ago. Histological examination
of the tumour revealed a 4 cm invasive lobular carcinoma
of histological grade 2. Two of the 20 lymph nodes exam-
ined were infiltrated by tumour cells. Immunohistochem-
istry for oestrogen and progesterone receptors showed
weak staining of 20% of cancer cells for both receptors.
There was no evidence of distant metastases at the time of
diagnosis. The patient received six cycles of adjuvant
chemotherapy (cyclophosphamide 500 mg/m2, mitox-
antrone 10 mg/m2, 5-fluorouracil 500 mg/m2, every 21
days) and was on tamoxifen. Ten years later a local recur-
rence occurred, and the patient underwent partial resec-
tion of the thorax wall followed by reconstruction by
transverse rectus abdominis musculocutaneus (TRAM)
flap technique. No adjuvant treatment was given. The
patient came to our attention complaining of a 4-month
history of diffuse abdominal pain associated to constipa-
tion, tenesmus and sporadic rectal bleeding. On physical
examination, the patient was pale but moderately nour-
ished. The mastectomy bed, the controlateral breast, and
both axilla were normal. Abdominal examination showed
no palpable mass or ascites. At digital examination the
rectum appeared stenotic from about 6 cm above the anal
verge, but without evidence of endoluminal masses. Hae-
matological analysis and biochemical parameters includ-
ing liver and renal function tests were within the normal
range. The urine cytology revealed micro-hematuria. The
patient was submitted to a rectosigmoidoscopy which
showed a diffuse thickening of the anterior wall of the rec-
tum, which determined mild stenosis beginning 7 cm
above the anal verge, without evidence of endoluminal
masses. The mucosa which lined the anterior rectal wall
was hyperaemic and easily bleeding. The posterior wall of
the vagina showed diffuse thickening at vaginal endos-
copy. The histological examination of multiple biopsies
taken during rectosigmoidoscopy, revealed an extensive
infiltration by scarcely cohesive neoplastic cells with
"Indian file" features and focal targettoid arrangement
around rectal glands (Fig 1, 2). The vaginal biopsy con-
firmed a prevalent "Indian file" neoplastic growth pattern
(Fig. 3). In both biopsies malignant cells were small, with
atypical nuclei and vacuolated cytoplasm, often with "sig-
net ring" morphology. The rectal glands and the vaginal
epithelium showed no atypias A panel of selected immu-
nohistochemical markers was used to confirm the meta-
static nature of the neoplastic mass and its site of origin.
Immunohistochemical stainings for oestrogen and pro-
gesterone receptors (Fig 4), GFCDP-15, C-ERB-B2 and CK
7 were positive. Otherwise, they resulted negative for CK
20, WT-1, CA-125 and CDX-2. This immunohistochemi-
cal pattern, together with the typical morphological pic-
ture showed above, let us confirm the diagnosis of
metastatic location from ILC.
A computerised tomography (CT) scan of the abdomen
and pelvis showed how the pelvic cavity was almost com-
pletely occupied by neoplastic tissue which infiltrated the
rectal wall, causing marked stenosis, both the ovaries, the
fundus of the vagina and the left lateral wall of the blad-
der, with involvement of the left ureter and concurrent
hydronephrosis. Multiple enlarged lymph-nodes were
identified in the perirectal fat, along the common iliac
artery and the obturator chain and in the inter-aortocaval
space. The liver and the chest appeared normal. Mammo-
graphic and ultrasonographic picture of the left breast and
of both axilla were normal. On the basis of the diagnosis
of wide peritoneal and extraperitoneal metastatic spread
of ILC, the patient entered a protocol of systemic chemo-
therapy and hormonal therapy after the placement of a J
ureteral stent to pass through the stenosis evidenced by
the CT scan and confirmed by cystoscopy.
Discsussion
It is well known that the pattern of metastatic spread dif-
fers dramatically between ductal and lobular breast cancer
[6,7]. In particular, the retrospective series by Borst et al,
comparing metastatic rates between these 2 histological
subtypes in 2605 cases of breast cancer, showed statisti-
cally significant differences for metastases in the gastroin-
testinal tract (4,5% in ILC vs 0,2% in DC), gynaecological
organs (4,5% in ILC vs 0,8 in DC) and peritoneum/retro-
peritoneum (3,1% in ILC vs 0,6% in DC) [7]. The 50% of
metastasis to the gastrointestinal tract from ILC affects the
small bowel [7] while involvement of the large bowel,
especially of the rectum, is infrequent [8] and often multi-
focal [9]. The metastatic spread may develop into the per-
itoneum, in the form of small or confluent nodules [10],
or into the retroperitoneum, often resulting in ureteric
obstruction and hydronephrosis [11]. Only 19 cases of
bladder location of metastases from breast cancer are
reported in the English literature till 2000 and only 33%
were secondary to ILC among them [12]. The gynaecolog-
ical organs are not spared by metastatic spread from ILC,
expecially the uterus and the ovary, which account for the
80% of all gynaecological metastastases from ILC [13].BMC Cancer 2006, 6:193 http://www.biomedcentral.com/1471-2407/6/193
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Concomitant multiple peritoneal and extraperitoneal
locations of metastatic disease from ILC, as in the case
reported, is an even more rare evenience; to the best of our
knowledge, apart from the present report, only other two
cases have been published in literature till know [11,14].
The most representative series of metastatic ILC, focused
on the specific sites of involvement, are summarized in
table I [see additional file 1].
The clinical manifestations in such cases are usually non-
specific, and strikingly similar to that of primary gastroin-
testinal and genitourinary malignancies [15,16]. The
median interval between presentation of metastasis and
diagnosis of ILC is five to six years [8,15]; an interval of
more than 10 years, up to 15 years as in our case, have
rarely been described [8,15,17]. Both the above reported
conditions make differential diagnosis between a primary
tumour and metastatic ILC, difficult. Moreover, if the clin-
ical picture is often inconclusive, also conventional imag-
ing techniques and endoscopy show potential limitations
in obtaining a differential diagnosis [8,15,16,18,19]. At
CT scan our case showed a picture that may be considered
typical, made of huge parietal thickening of several pelvic
organs such as rectum, bladder and vagina, as well as
bilateral hydronephrosis due to retroperitoneal involve-
ment. This characteristic infiltrative pattern of diffusion is
non-specific for metastatic desease from breast cancer, as
may resemble the picture of primary neoplasms of gas-
trointestinal or genitourinary systems. A recent report
failed to demonstrate any diagnostic advantage of MRI
and PET [11]. Endoscopy with biopsy appears an essential
step in the diagnostic work up, as it is showed in the
present case: we found the typical endoscopic picture of a
Rectum biopsy: Infiltration by ILC with focal targettoid arrangement around rectal glands Figure 1
Rectum biopsy: Infiltration by ILC with focal targettoid arrangement around rectal glands. The rectal glandular epithelium 
shows no dysplastic changes (original magnification ×100).BMC Cancer 2006, 6:193 http://www.biomedcentral.com/1471-2407/6/193
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colorectal metastatic lesion, characterized by diffuse thick-
ening and rigidity of the rectal wall, but no endoluminal
masses. Histological finding on biopsy samples gave us
the definitive confirmation of the metastatic nature of the
lesion. As already stressed in most recent reports, the com-
mon finding of a "signet ring" pattern neoplasia can be
misleading, as it may suggest a primitive origin from the
gastro-intestinal tract [20], but the lack of dysplasia or aty-
pia of the rectal glandular epithelium let us state the met-
astatic nature of the malignancy, and the specific origin
from ILC was strongly suggested by the typical "Indian
file" arrangement of the neoplastic cells [19,21]. A further
confirmation came from immunohistochemistry. Meta-
static breast carcinomas are often positive for Cytokeratin
7(CK7), GCDFP-15, ER and/or PgR. This was true in our
case. Moreover, the immunohistochemical negativity for
CA125 and WT1 ruled out a possible ovarian origin and
the negativity for Cytokeratin 20(CK20) and CDX2
excluded the colic one [22,23]. (Table 2) [see additional
file 1]
The therapeutic approach to these patients is still object of
debate. Surgery is mainly indicated to solve stenotic or
hemorrhagic evolution of the colorectal locations.
Although some authors suggest a potential benefit of sur-
gical debulking procedures followed by chemotherapy
[24], systemic treatment (chemotherapy, endocrine treat-
ment or both) is considered the therapy of choice in
patients with metastases to the peritoneum and retroperi-
toneum involving multiple organs [8,15]. The prognosis
remains poor with a partial response in about 50% of
patients and a median survival time from diagnosis of
about 1 year [8]. Many authors suggest the importance of
early diagnosis, which enables prompt initiation of sys-
A detail of the typical "Indian file" growth pattern of breast lobular invasive carcinoma (original magnification ×200) Figure 2
A detail of the typical "Indian file" growth pattern of breast lobular invasive carcinoma (original magnification ×200).BMC Cancer 2006, 6:193 http://www.biomedcentral.com/1471-2407/6/193
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temic treatment, with or without surgery, thus giving
advantage in terms of survival.
Conclusion
The case reported is peculiar, as it focuses on an extremely
rare condition which, if ignored, leads to a delayed treat-
ment, thus worsening the prognosis in terms of survival.
The long and complex diagnostic workup described,
draws the attention to the difficulty of making a correct
diagnosis, also because the long interval after the initial
diagnosis of breast cancer makes the occurrence of metas-
tasic disease an unexpected event.
This report stresses the importance for the clinician to be
aware of the eventuality of a wide peritoneal/extraperito-
neal metastatic diffusion, when dealing with a patient
with previous diagnosis of ILC and presenting for gas-
trointestinal or genitourinary symptoms. Only bearing in
mind such a possibility, the aggressive, multidisciplinary
approach necessary to make diagnosis can be early under-
taken and an optimal therapeutic approach promptly per-
formed.
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